Author:
Carter Nicholas J,Hill N E,Nicol E D,Hollis S,Patil Mead M L,Thompson G R
Reference31 articles.
1. An overview of the new frontiers in the treatment of atherogenic dyslipidemias;Rached;Clin Pharmacol Ther,2014
2. The role of fibrate treatment in dyslipidemia: an overview;Katsiki;Curr Pharm Des,2013
3. Familial dyslipidaemias: an overview of genetics, pathophysiology and management;Hachem;Drugs,2006
4. Office of National Statistics. Health statistics Quarterly No 33. Spring 2007. http://www.ons.gov.uk/ons/taxonomy/search/index.html?pageSize=50&sortBy=none&sortDirection=none&newquery=hsq+33&nscl=Health+and+Social+Care (accessed 4 Aug 2014).
5. World Health Organisation. The World Health Report 2002. Reducing risks, promoting healthy life. World Health Organisation, 2002. http://www.who.int/whr/2002/en (accessed 4 Aug 2013).